Patients treated with ANX005 were approximately twice as likely to be in a better state of health than patients on IVIg or PE on the GBS-Disability Scale at multiple timepoints throughout the ...
The study indicates ANX005 provides earlier and greater improvements in muscle strength and disability compared to IVIg or PE for GBS patients. ANX005 demonstrated faster recovery, reduced need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback